Status | Study |
Recruiting |
Study Name: Sunitinib or Cediranib for Alveolar Soft Part Sarcoma Condition: Sarcoma, Alveolar Soft Part Date: 2011-07-09 Interventions: Drug: Cediranib Cediranib, a s |
Active, not recruiting |
Study Name: A Trial of Cediranib in the Treatment of Patients With Alveolar Soft Part Sarcoma (CASPS) Condition: Alveolar Soft-part Sarcoma Date: 2011-04-11 Interventions: Drug: Cediranib 30mg once dail |
Terminated |
Study Name: Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma Condition: Sarcoma Date: 2010-08-25 Interventions: Drug: doxorubicin hydrochloride Drug: trab |
Completed |
Study Name: Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma Condition: Adult Alveolar Soft Part Sarcoma Adult Angiosarcoma Date: 2010-06-29 Interventions: Drug: Gamma-Secretase Inhibitor RO4929097 |
Terminated |
Study Name: Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer Condition: Cancer Date: 2010-05-26 Interventions: Drug: cyproheptadine hydrochloride |
Recruiting |
Study Name: Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma Condition: Sarcoma, Alveolar Soft Part Date: 2009-07-18 Interventions: Drug: AZD2171 Cediranib (AZD2171), a VEGF/KIT tyrosine kinase inhibitor, has demonstrated antitumor acti |
Terminated |
Study Name: Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma Condition: Sarcoma Date: 2008-08-22 Interventions: Genetic: gene expression analysis Genetic: |
Completed |
Study Name: Phase 2 Study in Patients With MiT Tumors Condition: Renal Cell Carcinoma (RCC) Alveolar Soft Part Sarcoma (ASPS) Date: 2007-11-12 Interventions: Drug: ARQ 197 360 mg administered twice daily until disease progression or other discontinuation criteri |
Completed |
Study Name: BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors Condition: Breast Cancer Endometrial Cancer Head and Neck Cancer Date: 2007-09-05 Interventions: Drug: BI 2536 Other: high performance liqu |
Completed |
Study Name: Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas Condition: Adult Malignant Fibrous Histiocytoma of Bone Desmoid Tumor Date: 2007-05-16 Interventions: Drug: sunitinib malate |